Express Scripts' 2016 Formulary Continues Exclusion Of Gilead’s Harvoni

The pharmacy benefit manager released its national preferred formulary for 2016. AbbVie’s Viekira Pak remains the preferred alternative for hepatitis C, while Harvoni remains blocked from coverage.